Literature DB >> 9821053

Significance of presence of teratomatous elements in the primary tumour of testicular cancer.

K Suzuki1, H Nakazato, K Matsumoto, K Kurokawa, T Suzuki, K Suzuki1, H Yamanaka.   

Abstract

To assess the tumour aggressiveness of teratoma, clinical records of patients with non-seminomatous germ cell testicular cancer were reviewed. Teratomatous elements were found in 57.8% of tumours. The rate of stage I tumours was lower in the teratoma-positive group than in the teratoma-negative group. Lymph node metastasis occurred more frequently than haematogenous metastasis in the teratoma-positive group. Tumour marker response in metastatic stage of teratoma-positive group was very excellent. Even if the radiographic response was not good, most patients were alive without disease after postchemotherapeutic salvage surgery. Furthermore, two patients with pure teratoma, who had tumour recurrence, were successfully treated with the multimodal therapy. Considering the smaller number of stage I patients in the teratoma-positive group than in the teratoma-negative group, the excellent overall response in the teratoma-positive group showed less aggressiveness of the tumour as a whole.

Entities:  

Mesh:

Year:  1998        PMID: 9821053     DOI: 10.1007/bf02550230

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

Review 1.  Prognostic assessment in nonseminomatous testicular cancer: implications for therapy.

Authors:  P J Hesketh; R J Krane
Journal:  J Urol       Date:  1990-07       Impact factor: 7.450

2.  Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance.

Authors:  K I Wishnow; D E Johnson; D A Swanson; D M Tenney; R J Babaian; C H Dunphy; A G Ayala; J Y Ro; A C von Eschenbach
Journal:  Urology       Date:  1989-12       Impact factor: 2.649

3.  Metastatic testicular germ cell tumour: the role of salvage surgery.

Authors:  K Suzuki; K Kurokawa; T Suzuki; S Jinbo; M Kobayashi; K Imai; H Yamanaka
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

4.  Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology.

Authors:  C Y Fung; L A Kalish; G L Brodsky; J P Richie; M B Garnick
Journal:  J Clin Oncol       Date:  1988-09       Impact factor: 44.544

5.  Primary pure teratoma of the testis.

Authors:  P D Simmonds; A H Lee; J M Theaker; K Tung; C J Smart; G M Mead
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

Review 6.  Prognostic features of primary and metastatic testis germ-cell tumors.

Authors:  H S Levin
Journal:  Urol Clin North Am       Date:  1993-02       Impact factor: 2.241

7.  VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis.

Authors:  D Vugrin; W F Whitmore; R B Golbey
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

8.  Carboplatin-based combination chemotherapy for testicular cancer: relationship among administration dose of carboplatin, renal function and myelosuppression.

Authors:  K Suzuki; K Matsumoto; K Hashimoto; K Kurokawa; S Jinbo; T Suzuki; K Imai; H Yamanaka; K Kawashima; H Takahashi
Journal:  Hinyokika Kiyo       Date:  1995-10

9.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

10.  The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).

Authors:  M J Peckham; A Barrett; K H Liew; A Horwich; B Robinson; H J Dobbs; T J McElwain; W F Hendry
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.